Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02706561 · ClinicalTrials.gov registry record · NA

Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery

A NA study of Prostate Cancer and Erectile Dysfunction, sponsored by Memorial Sloan Kettering Cancer Center.

Recruiting
Registry status
NA
Development phase
224
Enrollment target
1
Study location

NCT02706561 is a NA study of Prostate Cancer and Erectile Dysfunction that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 224 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02706561, a NA study of Prostate Cancer and Erectile Dysfunction, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.

RECRUITING
Registry status
NA
Development phase
224 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to test two different ways to help men with sexual rehabilitation.

Interventions

  • BEHAVIORAL questionnaires
  • BEHAVIORAL three in-person sessions
  • BEHAVIORAL monthly phone calls
  • BEHAVIORAL Acceptance and Commitment Therapy for Erectile Dysfunction (ACT-ED)
  • BEHAVIORAL Enhanced Monitoring and Education (EME)

Study Locations (1)

New York

  • Memorial Sloan Kettering Cancer Center - New York

Trial Details

FieldValue
Enrollment Target 224 participants
Start Date 2015-12-08
Est. Completion 2026-12
Phase NA

Sponsor

Memorial Sloan Kettering Cancer Center

1,884 total trials

What the Registry Record Tells You About NCT02706561

The ClinicalTrials.gov registry entry for NCT02706561 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 224 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (63% lower). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Prostate Cancer appearing as the primary indexed condition, and to 5 interventions - of which questionnaires is the first listed.

NCT02706561 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT02706561 about?

NCT02706561 is a clinical study titled "Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery". The purpose of this study is to test two different ways to help men with sexual rehabilitation.

What is the current status of trial NCT02706561?

This trial is currently recruiting. It is a NA study. The enrollment target is 224 participants. The study started on 2015-12-08. Estimated completion is 2026-12.

What conditions does trial NCT02706561 study?

This clinical trial studies the following conditions: Prostate Cancer, Erectile Dysfunction.

What interventions are being tested in trial NCT02706561?

The interventions under investigation include: questionnaires (BEHAVIORAL), three in-person sessions (BEHAVIORAL), monthly phone calls (BEHAVIORAL), Acceptance and Commitment Therapy for Erectile Dysfunction (ACT-ED) (BEHAVIORAL), Enhanced Monitoring and Education (EME) (BEHAVIORAL).

Who is sponsoring clinical trial NCT02706561?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02706561 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.